Minutes of the COMP meeting 3-5 December 2024
Minutes of the COMP meeting 3-5 December 2024
Minutes of the COMP meeting 3-5 December 2024
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 33, Status: Authorised
Agenda of the CVMP meeting 11-13 February 2025
Jakavi-H-C-002464-X-0070-G : EPAR - Assessment report - Variation
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised
Applications for new human medicines under evaluation: February 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 February 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025 to 13 February 2025
Agenda of the PRAC meeting 10-13 February 2025